SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-006164
Filing Date
2018-05-03
Accepted
2018-05-03 08:23:24
Documents
5
Period of Report
2018-04-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 50542
2 ex3-1.htm EX-3.1 295720
3 ex4-1.htm EX-4.1 155370
4 ex4-2.htm EX-4.2 102217
5 ex10-1.htm EX-10.1 310240
  Complete submission text file 0001493152-18-006164.txt   915586
Mailing Address 30 SHAHAM STREET P.O. BOX 8324 PETACH TIQWA L3 4918103
Business Address 30 SHAHAM STREET P.O. BOX 8324 PETACH TIQWA L3 4918103 972-3-919-1921
OWC Pharmaceutical Research Corp. (Filer) CIK: 0001431934 (see all company filings)

IRS No.: 980573566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54856 | Film No.: 18801886
SIC: 3841 Surgical & Medical Instruments & Apparatus